334 related articles for article (PubMed ID: 36809085)
1. Ribavirin Treatment Failure-Associated Mutation, Y1320H, in the RNA-Dependent RNA Polymerase of Genotype 3 Hepatitis E Virus (HEV) Enhances Virus Replication in a Rabbit HEV Infection Model.
Wang B; Mahsoub HM; Li W; Heffron CL; Tian D; Hassebroek AM; LeRoith T; Meng XJ
mBio; 2023 Apr; 14(2):e0337222. PubMed ID: 36809085
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis E virus mutations associated with ribavirin treatment failure result in altered viral fitness and ribavirin sensitivity.
Debing Y; Ramière C; Dallmeier K; Piorkowski G; Trabaud MA; Lebossé F; Scholtès C; Roche M; Legras-Lachuer C; de Lamballerie X; André P; Neyts J
J Hepatol; 2016 Sep; 65(3):499-508. PubMed ID: 27174035
[TBL] [Abstract][Full Text] [Related]
3. Modelling of Hepatitis E virus RNA-dependent RNA polymerase genotype 3 from a chronic patient and
Cancela F; Rendon-Marin S; Quintero-Gil C; Houston DR; Gumbis G; Panzera Y; Pérez R; Arbiza J; Mirazo S
J Biomol Struct Dyn; 2023 Feb; 41(2):705-721. PubMed ID: 34861797
[TBL] [Abstract][Full Text] [Related]
4. Zinc Salts Block Hepatitis E Virus Replication by Inhibiting the Activity of Viral RNA-Dependent RNA Polymerase.
Kaushik N; Subramani C; Anang S; Muthumohan R; Shalimar ; Nayak B; Ranjith-Kumar CT; Surjit M
J Virol; 2017 Nov; 91(21):. PubMed ID: 28814517
[TBL] [Abstract][Full Text] [Related]
5. Two mutations in the ORF1 of genotype 1 hepatitis E virus enhance virus replication and may associate with fulminant hepatic failure.
Wang B; Tian D; Sooryanarain H; Mahsoub HM; Heffron CL; Hassebroek AM; Meng XJ
Proc Natl Acad Sci U S A; 2022 Aug; 119(34):e2207503119. PubMed ID: 35969750
[TBL] [Abstract][Full Text] [Related]
6. High dose sofosbuvir and sofosbuvir-plus-ribavirin therapy inhibit Hepatitis E Virus (HEV) replication in a rabbit model for acute HEV infection.
Liang Z; Shu J; He Q; Zhang F; Dai L; Wang L; Lu F; Wang L
Antiviral Res; 2022 Mar; 199():105274. PubMed ID: 35247472
[TBL] [Abstract][Full Text] [Related]
7. Positive Regulation of Hepatitis E Virus Replication by MicroRNA-122.
Haldipur B; Bhukya PL; Arankalle V; Lole K
J Virol; 2018 Jun; 92(11):. PubMed ID: 29540601
[TBL] [Abstract][Full Text] [Related]
8. Mutagenic Effects of Ribavirin on Hepatitis E Virus-Viral Extinction versus Selection of Fitness-Enhancing Mutations.
Todt D; Walter S; Brown RJ; Steinmann E
Viruses; 2016 Oct; 8(10):. PubMed ID: 27754363
[TBL] [Abstract][Full Text] [Related]
9. A mutation in the hepatitis E virus RNA polymerase promotes its replication and associates with ribavirin treatment failure in organ transplant recipients.
Debing Y; Gisa A; Dallmeier K; Pischke S; Bremer B; Manns M; Wedemeyer H; Suneetha PV; Neyts J
Gastroenterology; 2014 Nov; 147(5):1008-11.e7; quiz e15-6. PubMed ID: 25181691
[TBL] [Abstract][Full Text] [Related]
10. In vivo evidence for ribavirin-induced mutagenesis of the hepatitis E virus genome.
Todt D; Gisa A; Radonic A; Nitsche A; Behrendt P; Suneetha PV; Pischke S; Bremer B; Brown RJ; Manns MP; Cornberg M; Bock CT; Steinmann E; Wedemeyer H
Gut; 2016 Oct; 65(10):1733-43. PubMed ID: 27222534
[TBL] [Abstract][Full Text] [Related]
11. Fetal Loss in Pregnant Rabbits Infected with Genotype 3 Hepatitis E Virus Is Associated with Altered Inflammatory Responses, Enhanced Virus Replication, and Extrahepatic Virus Dissemination with Positive Correlations with Increased Estradiol Level.
Mahsoub HM; Heffron CL; Hassebroek AM; Sooryanarain H; Wang B; LeRoith T; Rodríguez GR; Tian D; Meng XJ
mBio; 2023 Apr; 14(2):e0041823. PubMed ID: 36939322
[TBL] [Abstract][Full Text] [Related]
12. Infectivity and pathogenicity of different hepatitis E virus genotypes/subtypes in rabbit model.
Li S; He Q; Yan L; Li M; Liang Z; Shu J; Zhang F; Wang L; Wang L
Emerg Microbes Infect; 2020 Dec; 9(1):2697-2705. PubMed ID: 33251979
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis E virus treatment and ribavirin therapy: viral mechanisms of nonresponse.
Todt D; Meister TL; Steinmann E
Curr Opin Virol; 2018 Oct; 32():80-87. PubMed ID: 30384328
[TBL] [Abstract][Full Text] [Related]
14. The natural compound silvestrol inhibits hepatitis E virus (HEV) replication in vitro and in vivo.
Todt D; Moeller N; Praditya D; Kinast V; Friesland M; Engelmann M; Verhoye L; Sayed IM; Behrendt P; Dao Thi VL; Meuleman P; Steinmann E
Antiviral Res; 2018 Sep; 157():151-158. PubMed ID: 30036559
[TBL] [Abstract][Full Text] [Related]
15. Diversity of hepatitis E virus genotype 3.
Nicot F; Jeanne N; Roulet A; Lefebvre C; Carcenac R; Manno M; Dubois M; Kamar N; Lhomme S; Abravanel F; Izopet J
Rev Med Virol; 2018 Sep; 28(5):e1987. PubMed ID: 29939461
[TBL] [Abstract][Full Text] [Related]
16. Identification of structurally re-engineered rocaglates as inhibitors against hepatitis E virus replication.
Praditya DF; Klöhn M; Brüggemann Y; Brown LE; Porco JA; Zhang W; Kinast V; Kirschning A; Vondran FWR; Todt D; Steinmann E
Antiviral Res; 2022 Aug; 204():105359. PubMed ID: 35728703
[TBL] [Abstract][Full Text] [Related]
17. Drug repurposing screen identifies vidofludimus calcium and pyrazofurin as novel chemical entities for the development of hepatitis E interventions.
Guo H; Liu D; Liu K; Hou Y; Li C; Li Q; Ding X; Verstegen MMA; Zhang J; Wang L; Ding Y; Tang R; Pan X; Zheng K; van der Laan LJW; Pan Q; Wang W
Virol Sin; 2024 Feb; 39(1):123-133. PubMed ID: 37984761
[TBL] [Abstract][Full Text] [Related]
18. Robust hepatitis E virus infection and transcriptional response in human hepatocytes.
Todt D; Friesland M; Moeller N; Praditya D; Kinast V; Brüggemann Y; Knegendorf L; Burkard T; Steinmann J; Burm R; Verhoye L; Wahid A; Meister TL; Engelmann M; Pfankuche VM; Puff C; Vondran FWR; Baumgärtner W; Meuleman P; Behrendt P; Steinmann E
Proc Natl Acad Sci U S A; 2020 Jan; 117(3):1731-1741. PubMed ID: 31896581
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of active hepatitis E virus infection and efficacy of ribavirin treatment in renal allograft recipients.
Friebus-Kardash J; Eisenberger U; Ackermann J; Kribben A; Witzke O; Wenzel J; Rohn H; Fiedler M
Transpl Infect Dis; 2019 Jun; 21(3):e13088. PubMed ID: 30929308
[TBL] [Abstract][Full Text] [Related]
20. Persistent infection with a rabbit hepatitis E virus created by a reverse genetics system.
Zhang W; Ami Y; Suzaki Y; Doan YH; Jirintai S; Takahashi M; Okamoto H; Takeda N; Muramatsu M; Li TC
Transbound Emerg Dis; 2021 Mar; 68(2):615-625. PubMed ID: 32649803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]